Avalo Therapeutics (AVTX) Amortization - Intangibles (2017 - 2022)
Avalo Therapeutics posted quarterly Amortization - Intangibles of $38000.0 for Q1 2022, down 91.04% year-on-year from $424000.0 in Q1 2021, and down 85.77% on a QoQ basis from $267000.0 in Q4 2021.
Avalo Therapeutics (AVTX) has 6 years of Amortization - Intangibles data on file, last reported at $38000.0 in Q1 2022.
- For the quarter ending Q1 2022, Amortization - Intangibles fell 91.04% year-over-year to $38000.0; the trailing twelve-month figure through Dec 2022 stood at $38000.0 (down 97.54% YoY), and the FY2022 full-year result was $38000.0, down 97.55% from the prior year.
- Amortization - Intangibles for Q1 2022 stood at $38000.0, down from $267000.0 in the prior quarter.
- Across five years, Amortization - Intangibles topped out at $1.2 million in Q2 2018 and bottomed at -$1.5 million in Q4 2018.
- The 5-year median for Amortization - Intangibles is $404000.0 (2020), against an average of $382032.1.
- The widest annual swing landed in 2018, when Amortization - Intangibles plunged 468.58%; it then soared 122.51% in 2019.
- A 5-year view of Amortization - Intangibles shows it stood at -$1.5 million in 2018, then jumped by 122.51% to $334753.0 in 2019, then jumped by 50.26% to $503000.0 in 2020, then plunged by 46.92% to $267000.0 in 2021, then sank by 85.77% to $38000.0 in 2022.
- The last three Amortization - Intangibles figures came in at $38000.0 (Q1 2022), $267000.0 (Q4 2021), and $428000.0 (Q3 2021), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Avalo Therapeutics | 317.29 Mn | 317.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 38,000.00 |
| Dec 31, 2021 | 267,000.00 |
| Sep 30, 2021 | 428,000.00 |
| Jun 30, 2021 | 428,000.00 |
| Mar 31, 2021 | 424,000.00 |
| Dec 31, 2020 | 503,000.00 |
| Sep 30, 2020 | 404,000.00 |
| Jun 30, 2020 | 404,000.00 |
| Mar 31, 2020 | 431,000.00 |
| Dec 31, 2019 | 334,753.00 |
| Sep 30, 2019 | 334,748.00 |
| Jun 30, 2019 | 334,747.00 |
| Mar 31, 2019 | 334,748.00 |
| Dec 31, 2018 | -1.49 Mn |
| Sep 30, 2018 | 1.07 Mn |
| Jun 30, 2018 | 1.23 Mn |
| Mar 31, 2018 | 1.02 Mn |
| Dec 31, 2017 | 403,520.00 |